Stocks ARM Financial statements
Financial statementsARM HOLDINGS PLC /UK financial statements
Income statement, balance sheet and cash flow statement for the last 5 fiscal years, taken from the XBRL data ARM HOLDINGS PLC /UK files with the SEC in its annual reports.
In USD millions, except per-share amounts. Outflows in the cash flow statement are negative.
Income statement
| FY2022 | FY2024 | FY2024 | FY2025 | FY2026 | |
|---|---|---|---|---|---|
| Revenue | 2,703 | 2,679 | 3,233 | 4,007 | 4,920 |
| Cost of revenue | 131 | 106 | 154 | 121 | 121 |
| Gross profit | 2,572 | 2,573 | 3,079 | 3,886 | 4,799 |
| Research and development | 995 | 1,133 | 1,979 | 2,071 | 2,776 |
| Selling, general and administrative | 897 | 762 | 983 | 984 | 1,115 |
| Operating expenses | 1,939 | 1,902 | 2,968 | 3,055 | 3,899 |
| Operating income | 633 | 671 | 111 | 831 | 900 |
| Other non-operating income | 10 | 3 | 11 | 10 | 132 |
| Pre-tax income | 786 | 671 | 212 | 720 | 1,157 |
| Income tax | 110 | 147 | -94 | -72 | 253 |
| Income from continuing operations | 676 | 524 | 306 | ||
| Net income | 549 | 524 | 306 | 792 | 904 |
| EBITDA | 818 | 841 | 273 | 1,014 | 1,149 |
| EPS, basic | 0.54 | 0.51 | 0.30 | 0.75 | 0.85 |
| EPS, diluted | 0.54 | 0.51 | 0.29 | 0.75 | 0.85 |
| Shares, basic (weighted) | 1,025 | 1,025 | 1,027 | 1,050 | 1,061 |
| Shares, diluted (weighted) | 1,025 | 1,028 | 1,044 | 1,063 | 1,068 |
Balance sheet
| FY2022 | FY2024 | FY2024 | FY2025 | FY2026 | |
|---|---|---|---|---|---|
| Cash and equivalents | 1,004 | 1,554 | 1,923 | 2,085 | 2,751 |
| Short-term investments | 661 | 1,000 | 740 | 850 | |
| Receivables | 999 | 781 | 1,107 | 1,300 | |
| Other current assets | 169 | 157 | 256 | 358 | |
| Total current assets | 3,537 | 4,197 | 4,830 | 6,236 | |
| Property, plant and equipment | 185 | 215 | 354 | 772 | |
| Lease right-of-use assets | 206 | 205 | 320 | 379 | |
| Goodwill | 1,620 | 1,625 | 1,620 | 1,623 | |
| Intangible assets | 138 | 152 | 151 | 230 | |
| Long-term investments | 723 | 741 | 565 | 387 | |
| Other non-current assets | 202 | 270 | 305 | 312 | |
| Total assets | 6,866 | 7,927 | 8,932 | 10,703 | |
| Accounts payable | 82 | 26 | 63 | 80 | |
| Accrued liabilities | 589 | 298 | 140 | 154 | |
| Deferred revenue | 293 | 198 | 209 | 294 | |
| Total current liabilities | 1,363 | 1,505 | 929 | 1,040 | |
| Lease liabilities | 193 | 194 | 316 | 393 | |
| Other non-current liabilities | 38 | 61 | 79 | 161 | |
| Total liabilities | 2,815 | 2,632 | 2,093 | 2,417 | |
| Paid-in capital | 1,216 | 2,171 | 2,922 | 3,467 | |
| Retained earnings | 2,457 | 2,751 | 3,543 | 4,447 | |
| Other comprehensive income | 376 | 371 | 372 | 370 | |
| Shareholders' equity | 3,548 | 4,051 | 5,295 | 6,839 | 8,286 |
| Total equity | 3,548 | 4,051 | 5,295 | 6,839 | 8,286 |
| Total liabilities and equity | 6,866 | 7,927 | 8,932 | 10,703 | |
| Shares outstanding | 1,025 | 1,040 | 1,057 | 1,064 |
Cash flow statement
| FY2022 | FY2024 | FY2024 | FY2025 | FY2026 | |
|---|---|---|---|---|---|
| Net income | 549 | 524 | 306 | 792 | 904 |
| Depreciation and amortization | 185 | 170 | 162 | 183 | 249 |
| Stock-based compensation | 26 | 79 | 1,037 | 820 | 1,052 |
| Deferred income tax | -80 | -34 | -270 | -218 | 15 |
| Change in receivables | -219 | 125 | 218 | -331 | -201 |
| Cash from operations | 458 | 739 | 1,090 | 397 | 1,524 |
| Capital expenditures | -34 | -64 | -92 | -219 | -545 |
| Purchases of investments | -750 | -1,111 | -765 | -680 | -1,140 |
| Cash from investing | -619 | -138 | -516 | -35 | -325 |
| Cash from financing | -32 | -42 | -208 | -202 | -548 |
| Exchange rate effect | -17 | -9 | 3 | 2 | 15 |
| Net change in cash | -210 | 550 | 369 | 162 | 666 |
| Free cash flow | 424 | 675 | 998 | 178 | 979 |
| Interest paid | 1 | 0 | 0 | ||
| Income taxes paid | 141 | 157 | 187 | 149 | 223 |
Key metrics
Profitability
| Metric | Value | How it is calculated |
|---|---|---|
| Gross margin | 97.5% | Gross profit / revenue. |
| Operating margin | 18.3% | Operating income / revenue. |
| EBITDA margin | 23.4% | EBITDA (operating income + depreciation and amortization) / revenue. |
| Pre-tax margin | 23.5% | Pre-tax income / revenue. |
| Net margin | 18.4% | Net income / revenue. |
| FCF margin | 19.9% | Free cash flow (cash from operations - capital expenditures) / revenue. |
| Operating cash flow margin | 31.0% | Cash from operations / revenue. |
| Effective tax rate | 21.9% | Income tax / pre-tax income, when pre-tax income is positive. |
| Return on equity (ROE) | 12.0% | Net income / average shareholders' equity (opening and closing). Not shown when equity is negative. |
| Return on assets (ROA) | 9.2% | Net income / average total assets. |
| Return on invested capital (ROIC) | 13.7% | Approximation: operating income x (1 - tax rate) / average (total debt + equity - cash). Tax rate is the effective rate when between 0% and 50%, else 21%. |
| R&D / revenue | 56.4% | Research and development expense / revenue. |
| SG&A / revenue | 22.7% | Selling, general and administrative expense / revenue. |
| Stock-based pay / revenue | 21.4% | Stock-based compensation (from the cash flow statement) / revenue. |
| Capex / revenue | 11.1% | Capital expenditures / revenue. |
| D&A / revenue | 5.1% | Depreciation and amortization / revenue. |
Growth
| Metric | Value | How it is calculated |
|---|---|---|
| Revenue growth, 1y | 22.8% | Revenue vs the same period a year earlier. Only from a positive base. |
| Revenue CAGR, 3y | 22.5% | Compound annual growth of revenue over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive. |
| Gross profit growth, 1y | 23.5% | Gross profit vs the same period a year earlier. Only from a positive base. |
| Gross profit CAGR, 3y | 23.1% | Compound annual growth of gross profit over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive. |
| Operating income growth, 1y | 8.3% | Operating income vs the same period a year earlier. Only from a positive base. |
| Operating income CAGR, 3y | 10.3% | Compound annual growth of operating income over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive. |
| EBITDA growth, 1y | 13.3% | EBITDA vs the same period a year earlier. Only from a positive base. |
| EBITDA CAGR, 3y | 11.0% | Compound annual growth of ebitda over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive. |
| Net income growth, 1y | 14.1% | Net income vs the same period a year earlier. Only from a positive base. |
| Net income CAGR, 3y | 19.9% | Compound annual growth of net income over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive. |
| EPS growth, 1y | 13.3% | EPS vs the same period a year earlier. Only from a positive base. |
| EPS CAGR, 3y | 18.6% | Compound annual growth of eps over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive. |
| Operating cash flow growth, 1y | 283.9% | Operating cash flow vs the same period a year earlier. Only from a positive base. |
| Operating cash flow CAGR, 3y | 27.3% | Compound annual growth of operating cash flow over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive. |
| Free cash flow growth, 1y | 450.0% | Free cash flow vs the same period a year earlier. Only from a positive base. |
| Free cash flow CAGR, 3y | 13.2% | Compound annual growth of free cash flow over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive. |
| Book value growth, 1y | 21.2% | Book value vs the same period a year earlier. Only from a positive base. |
| Book value CAGR, 3y | 26.9% | Compound annual growth of book value over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive. |
| Total assets growth, 1y | 19.8% | Total assets vs the same period a year earlier. Only from a positive base. |
| Total assets CAGR, 3y | 15.9% | Compound annual growth of total assets over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive. |
| Share count change, 1y | 0.5% | Change in diluted weighted shares vs a year earlier. Negative means buybacks shrank the share count; positive means dilution. |
| Share count change per year, 3y | 1.3% | Change in diluted weighted shares, per year over 3 years. Negative means buybacks shrank the share count; positive means dilution. |
Balance sheet health
| Metric | Value | How it is calculated |
|---|---|---|
| Current ratio | 6.00x | Current assets / current liabilities. |
| Quick ratio | 4.71x | (Cash + short-term investments + receivables) / current liabilities. |
| Cash ratio | 3.46x | (Cash + short-term investments) / current liabilities. |
| Liabilities / assets | 22.6% | Total liabilities / total assets. |
| Working capital | $5.20B | Current assets - current liabilities. |
| Goodwill and intangibles / assets | 17.3% | (Goodwill + intangible assets) / total assets. |
| Tangible book value | $6.43B | Shareholders' equity - goodwill - intangible assets. |
Efficiency
| Metric | Value | How it is calculated |
|---|---|---|
| Asset turnover | 0.50x | Revenue / average total assets. |
| Fixed asset turnover | 8.74x | Revenue / average property, plant and equipment. |
| Receivables turnover | 4.09x | Revenue / average receivables. |
| Days sales outstanding | 89 days | 365 x average receivables / revenue. |
| Days payables | 216 days | 365 x average accounts payable / cost of revenue. |
| FCF conversion | 108.3% | Free cash flow / net income, when net income is positive. |
| Capex / operating cash flow | 35.8% | Capital expenditures / cash from operations, when that is positive. |
Per share
| Metric | Value | How it is calculated |
|---|---|---|
| EPS, diluted | $0.85 | Net income per diluted share, as reported (split-adjusted). Over the last twelve months: the four quarters summed, or net income / latest diluted shares when a quarter has no reported EPS. |
| EPS, basic | $0.85 | Net income per basic share, as reported (split-adjusted). |
| Revenue per share | $4.61 | Revenue / diluted weighted shares. |
| FCF per share | $0.92 | Free cash flow / diluted weighted shares. |
| Operating cash flow per share | $1.43 | Cash from operations / diluted weighted shares. |
| Book value per share | $7.79 | Shareholders' equity / shares outstanding (diluted weighted shares when not reported). |
| Tangible book per share | $6.05 | Tangible book value / shares outstanding. |
| Cash per share | $3.38 | (Cash + short-term investments) / shares outstanding. |
Valuation
| Metric | Value | How it is calculated |
|---|---|---|
| Market cap | $330.20B | Share price x shares outstanding. |
| Enterprise value | $326.60B | Market cap + total debt - cash - short-term investments. |
| P/E | 365x | Market cap / net income. Only when net income is positive. |
| P/S | 67.1x | Market cap / revenue. |
| P/B | 39.9x | Market cap / shareholders' equity. Only when equity is positive. |
| Price / tangible book | 51.3x | Market cap / tangible book value, when positive. |
| P/FCF | 337x | Market cap / free cash flow. Only when free cash flow is positive. |
| P/OCF | 217x | Market cap / cash from operations, when positive. |
| EV/Sales | 66.4x | Enterprise value / revenue. |
| EV/EBIT | 363x | Enterprise value / operating income, when both are positive. |
| EV/EBITDA | 284x | Enterprise value / EBITDA, when both are positive. |
| EV/FCF | 334x | Enterprise value / free cash flow, when both are positive. |
| FCF yield | 0.3% | Free cash flow / market cap. |
| Earnings yield | 0.3% | Net income / market cap (the inverse of P/E). |
| PEG | 19.7x | P/E / EPS growth per year over 3 years (in percent). Only when both are positive. |
What was ARM HOLDINGS PLC /UK's revenue in fiscal 2026?
ARM HOLDINGS PLC /UK reported revenue of $4.92B for fiscal 2026, 22.8% higher than the year before.
Was ARM HOLDINGS PLC /UK profitable in fiscal 2026?
Yes. Net income was $904.0M, a net margin of 18.4%.
How much free cash flow did ARM HOLDINGS PLC /UK generate in fiscal 2026?
Cash from operations of $1.52B minus capital expenditures of $545.0M left free cash flow of $979.0M.